Valuation Clinuvel Pharmaceuticals Limited Nasdaq

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-23 EDT			5-day change	1st Jan Change
4.940 ^USD	-1.79%		-5.64%	-41.75%

10-19	Disc Medicine's late-stage win clears path for approval of sun-allergy pill	RE
10-01	Clinuvel Pharmaceuticals Ltd Presents New Patient Cases Demonstrating Clinical Response To SCENESSE With Adjunct Narrowband Ultraviolet B Phototherapy In Vitiligo Patients To EADV	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	733.7	883.5	769.8	520.3	518.4	359	-	-
Change	-	20.4%	-12.87%	-32.41%	-0.36%	-30.74%	-	-
Enterprise Value (EV) ¹	612.2	726.6	585.9	296.2	309.1	75.94	43.43	5.94
Change	-	18.69%	-19.37%	-49.45%	4.37%	-75.44%	-42.81%	-86.32%
P/E	36.8x	30.3x	22x	14.5x	15.4x	10.3x	9.94x	6.97x
PBR	5.84x	5.37x	3.79x	2.17x	1.91x	1.18x	1.06x	0.93x
PEG	-	0.6x	1.2x	5.06x	-2.21x	3.1x	2.64x	0.2x
Capitalization / Revenue	11.2x	11.3x	8.73x	5.48x	5.51x	3.8x	3.58x	2.67x
EV / Revenue	9.32x	9.28x	6.64x	3.12x	3.29x	0.8x	0.43x	0.04x
EV / EBITDA	16.4x	19.5x	12x	6.84x	8.09x	2.01x	1.11x	0.1x
EV / EBIT	16.7x	20x	12.3x	7.03x	8.31x	2.07x	1.14x	0.11x
EV / FCF	15.5x	20.2x	18.6x	7.26x	8.76x	2.08x	1.08x	0.11x
FCF Yield	6.44%	4.94%	5.37%	13.8%	11.4%	48.2%	92.6%	940%
Dividend per Share ²	0.04	0.05	0.05	0.05	0.05	0.0547	0.0592	0.0832
Rate of return	0.27%	0.28%	0.33%	0.48%	0.49%	0.77%	0.83%	1.17%
EPS ²	0.403	0.591	0.698	0.718	0.668	0.6902	0.7162	1.021
Distribution rate	9.93%	8.46%	7.16%	6.96%	7.49%	7.92%	8.26%	8.15%
Net sales ¹	65.72	78.32	88.18	95.02	94.02	94.47	100.4	134.4
EBITDA ¹	37.44	37.2	48.95	43.3	38.2	37.75	39.3	57.96
EBIT ¹	36.68	36.41	47.81	42.12	37.21	36.65	38.13	56.47
Net income ¹	20.88	30.6	35.64	36.17	33.92	34.94	36.32	51.72
Net Debt ¹	-121.5	-156.8	-183.9	-224.1	-209.3	-283.1	-315.6	-353.1
Reference price ²	14.850	17.880	15.370	10.380	10.280	7.120	7.120	7.120
Nbr of stocks (in thousands)	49,410	49,410	50,083	50,124	50,428	50,428	-	-
Announcement Date	8/30/22	8/29/23	8/28/24	8/27/25	8/27/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.74x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.42x	4.53x	12.96x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.46x	7.04x	18.70x	2.12%	444.85B
Weighted average by Cap.	35.14x	8.29x	20.39x	1.8%